BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 38048037)

  • 1. Novel Biomarkers and Molecular Targets in ALL.
    De Sa H; Leonard J
    Curr Hematol Malig Rep; 2024 Feb; 19(1):18-34. PubMed ID: 38048037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?
    Chung C; Ma H
    Pharmacotherapy; 2017 Sep; 37(9):1052-1072. PubMed ID: 28654205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of recurrent, rare, and novel gene fusions in patients with acute leukemia using next-generation sequencing approaches.
    Kim B; Kim E; Lee ST; Cheong JW; Lyu CJ; Min YH; Choi JR
    Hematol Oncol; 2020 Feb; 38(1):82-88. PubMed ID: 31875988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities.
    Tran TH; Hunger SP
    Semin Cancer Biol; 2022 Sep; 84():144-152. PubMed ID: 33197607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular diagnostics in acute leukemias.
    Bacher U; Schnittger S; Haferlach C; Haferlach T
    Clin Chem Lab Med; 2009; 47(11):1333-41. PubMed ID: 19817644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
    Lu XT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-Molecule Sequencing Reveals Patterns of Preexisting Drug Resistance That Suggest Treatment Strategies in Philadelphia-Positive Leukemias.
    Schmitt MW; Pritchard JR; Leighow SM; Aminov BI; Beppu L; Kim DS; Hodgson JG; Rivera VM; Loeb LA; Radich JP
    Clin Cancer Res; 2018 Nov; 24(21):5321-5334. PubMed ID: 30042204
    [No Abstract]   [Full Text] [Related]  

  • 8. Oncogenic lesions and molecular subtypes in adults with B-cell acute lymphoblastic leukemia.
    Yasuda T; Sanada M; Tsuzuki S; Hayakawa F
    Cancer Sci; 2023 Jan; 114(1):8-15. PubMed ID: 36106363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia-Therapy and Toxicity Mechanisms.
    Lejman M; Kuśmierczuk K; Bednarz K; Ostapińska K; Zawitkowska J
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute leukemia in adults].
    Eigendorff E; Hochhaus A
    Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular-based and antibody-based targeted pharmacological approaches in childhood acute lymphoblastic leukemia.
    Tardif M; Souza A; Krajinovic M; Bittencourt H; Tran TH
    Expert Opin Pharmacother; 2021 Oct; 22(14):1871-1887. PubMed ID: 34011251
    [No Abstract]   [Full Text] [Related]  

  • 12. Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia.
    Heikamp EB; Pui CH
    J Pediatr; 2018 Dec; 203():14-24.e2. PubMed ID: 30213460
    [No Abstract]   [Full Text] [Related]  

  • 13. Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic
    Stukaite-Ruibiene E; Norvilas R; Dirse V; Stankeviciene S; Vaitkeviciene GE
    Pathol Oncol Res; 2022; 28():1610570. PubMed ID: 36172171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia.
    Safavi S; Hansson M; Karlsson K; Biloglav A; Johansson B; Paulsson K
    Haematologica; 2015 Jan; 100(1):55-61. PubMed ID: 25261097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic and germline genomics in paediatric acute lymphoblastic leukaemia.
    Pui CH; Nichols KE; Yang JJ
    Nat Rev Clin Oncol; 2019 Apr; 16(4):227-240. PubMed ID: 30546053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOHO State of the Art Update and Next Questions: Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
    Short NJ; Kantarjian H; Pui CH; Goldstone A; Jabbour E
    Clin Lymphoma Myeloma Leuk; 2018 Jul; 18(7):439-446. PubMed ID: 29853276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates in the biology and therapy for infant acute lymphoblastic leukemia.
    Guest EM; Stam RW
    Curr Opin Pediatr; 2017 Feb; 29(1):20-26. PubMed ID: 27841777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic Analyses of Pediatric Acute Lymphoblastic Leukemia Ph+ and Ph-Like-Recent Progress in Treatment.
    Kaczmarska A; Śliwa P; Zawitkowska J; Lejman M
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed Phenotype Acute Leukemia: Current Approaches to Diagnosis and Treatment.
    Alexander TB; Orgel E
    Curr Oncol Rep; 2021 Feb; 23(2):22. PubMed ID: 33544265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report.
    De Benedittis C; Papayannidis C; Venturi C; Abbenante MC; Paolini S; Parisi S; Sartor C; Cavo M; Martinelli G; Soverini S
    BMC Cancer; 2017 Aug; 17(1):523. PubMed ID: 28779753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.